Eugene Mosharov

Dr. Eugene Mosharov


Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 August 2005 in Nature Methods
Verified
Journal Article
Closed access
EMEugene Mosharov
Eugene Mosharov
DSDavid Sulzer
David Sulzer

12 January 2015 in Nature Biotechnology
Verified
Journal Article
Closed access
PDF file
JSJulius A Steinbeck
Julius A Steinbeck
SCSe Joon Choi
Se Joon Choi
AMAna Mrejeru
Ana Mrejeru
YGYosif Ganat
Yosif Ganat
KDKarl Deisseroth
Karl Deisseroth
LSLorenz Studer
Lorenz Studer

16 January 2023 in npj Parkinson's Disease
Verified
Journal Article
Open access
PDF file
NRNagendran Ramalingam
Nagendran Ramalingam
SJShan-Xue Jin
Shan-Xue Jin
TMTim E. Moors
Tim E. Moors
LFLuis Fonseca-Ornelas
Luis Fonseca-Ornelas
KSKazuma Shimanaka
Kazuma Shimanaka
UDUlf Dettmer
Ulf Dettmer
In Parkinson’s disease and other synucleinopathies, the elevation of α-synuclein phosphorylated at Serine129 (pS129) is a widely cited marker of pathology. However, the physiological role for pS129 has remained undefined. Here we use multiple approaches to show for the first time that pS129 functions as a physiological regulator of neuronal activity. Neuronal activity triggers a sustained increase of pS129 in cultured neurons (200% within 4 h). In accord, brain pS129 is elevated in environmentally enriched mice exhibiting enhanced long-term potentiation. Activity-dependent α-synuclein phosphorylation is S129-specific, reversible, confers no cytotoxicity, and accumulates at synapsin-containing presynaptic boutons. Mechanistically, our findings are consistent with a model in which neuronal stimulation enhances Plk2 kinase activity via a calcium/calcineurin pathway to counteract PP2A phosphatase activity for efficient phosphorylation of membrane-bound α-synuclein. Patch clamping of rat SNCA−/− neurons expressing exogenous wild-type or phospho-incompetent (S129A) α-synuclein suggests that pS129 fine-tunes the balance between excitatory and inhibitory neuronal currents. Consistently, our novel S129A knock-in (S129AKI) mice exhibit impaired hippocampal plasticity. The discovery of a key physiological function for pS129 has implications for understanding the role of α-synuclein in neurotransmission and adds nuance to the interpretation of pS129 as a synucleinopathy biomarker.

26 March 2025 in Nature
Verified
Journal Article
Closed access
PDF file
EMEugene Mosharov
Eugene Mosharov
ARAyelet M. Rosenberg
Ayelet M. Rosenberg
AMAnna S. Monzel
Anna S. Monzel
COCorey A. Osto
Corey A. Osto
LSLinsey Stiles
Linsey Stiles
MPMartin Picard
Martin Picard

14 March 2018 in Frontiers in Neuroscience
Verified
Journal Article
Open access
PDF file
MPMichael R. Post
Michael R. Post
OLOri J. Lieberman
Ori J. Lieberman
EMEugene Mosharov
Eugene Mosharov
Several lines of evidence place alpha-synuclein (aSyn) at the center of Parkinson's disease (PD) etiology, but it is still unclear why overexpression or mutated forms of this protein affect some neuronal populations more than others. Susceptible neuronal populations in PD, dopaminergic neurons of the substantia nigra pars compacta (SNpc) and the locus coeruleus (LC), are distinguished by relatively high cytoplasmic concentrations of dopamine and calcium ions. Here we review the evidence for the multi-hit hypothesis of neurodegeneration, including recent papers that demonstrate synergistic interactions between aSyn, calcium ions and dopamine that may lead to imbalanced protein turnover and selective susceptibility of these neurons. We conclude that decreasing the levels of any one of these toxicity mediators can be beneficial for the survival of SNpc and LC neurons, providing multiple opportunities for targeted drug interventions aimed at modifying the course of PD.

6 November 2017 in eneuro
Verified
Journal Article
Open access
PDF file
OLOri J. Lieberman
Ori J. Lieberman
SCSe Joon Choi
Se Joon Choi
EKEllen Kanter
Ellen Kanter
ASAnastasia Saverchenko
Anastasia Saverchenko
MFMicah D. Frier
Micah D. Frier
EMEugene Mosharov
Eugene Mosharov
Parkinson’s disease (PD) is a debilitating neurodegenerative disease characterized by a loss of dopaminergic neurons in the substantia nigra (SN). Although mitochondrial dysfunction and dysregulated α-synuclein (aSyn) expression are postulated to play a role in PD pathogenesis, it is still debated why neurons of the SN are targeted while neighboring dopaminergic neurons of the ventral tegmental area (VTA) are spared. Using electrochemical and imaging approaches, we investigated metabolic changes in cultured primary mouse midbrain dopaminergic neurons exposed to a parkinsonian neurotoxin, 1-methyl-4-phenylpyridinium (MPP+). We demonstrate that the higher level of neurotoxicity in SN than VTA neurons was due to SN neuron-specific toxin-induced increase in cytosolic dopamine (DA) and Ca2+, followed by an elevation of mitochondrial Ca2+, activation of nitric oxide synthase (NOS), and mitochondrial oxidation. The increase in cytosolic Ca2+was not caused by MPP+-induced oxidative stress, but rather depended on the activity of both L-type calcium channels and aSyn expression, suggesting that these two established pathogenic factors in PD act in concert.